As a partner of the EBRAINS 2.0 project, the EAN is leading the publication of the open-access European Journal of Neurology Special Issue, Digital Health Research in Clinical Neurosciences.

With the 12th EAN congress happening in Geneva this year, we think it is a good time to also think about the past and our great officers and speakers who have provided large amounts of content for EAN Activities throughout the last years

It is with deep sadness that we report the passing of our esteemed colleague and friend, Prof. Ivan Rektor

Matilde Leonardi reflects on four successful years as Chair of the Communication Committee.

The EAN Congress Special Advocacy Session 'Partnering for the Brain in Europe and Beyond' will bring together leading voices from across neurology, public health, patient advocacy, and international organisations.

The third edition of the Advocacy Training Programme for Neurology and Brain Health has concluded, marking another successful year of strengthening advocacy skills within the neurology community.

The International Bureau for Epilepsy (IBE) has unveiled a new global Policy Advocacy Report at the 79th World Health Assembly in Geneva, marking an important step in bringing the lived experience of people with epilepsy closer to global policymaking.

Report on a joint session between the Romanian Neurological Society's Young Neurologists’ Working Group and the EAN Resident & Research Fellow Section at the Romanian national neurology congress

The EAN Education Committee is happy to announce and introduce the recipients of the 2026 Student Teaser Fellowship

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for June 2026.

EAN Programme Committee Chair, Irena Rektorová, & EAN President, Elena Moro preview some major highlights of the EAN Congress 2026, taking place in Geneva in just a few weeks.

Welcome to the June 2026 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions

Results from the TRIDENT trial, testing a daily pill combining three low-dose blood-pressure medicines for people who have had an intracerebral haemorrhage.

At the EAN Congress 2026, the Dream-in-Experience capsule introduces a new way of addressing the challenge of communicating sleep and brain health

We are excited to bring back our very popular quiz show to the EAN Congress 2026 in Geneva - get ready for the 9th edition of the EAN BrainChallenge,